Andere talen Pfizer Limited Bombay S.E.

Aandelen

PFIZER

INE182A01018

Vertraagde tijd Bombay S.E. Andere beurzen 10:45:59 12-07-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
4.891 ^INR	-1,19%		+5,91%	+14,58%

17/05	Pfizer Limited rapporteert resultaten voor het vierde kwartaal en het volledige jaar eindigend op 31 maart 2024	CI
17/05	Pfizer Limited beveelt dividend aan voor het boekjaar dat eindigt op 31 maart 2024, betaalbaar op of voor 6 september 2024	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Pfizer Limited Receives an Order Issued by the Joint Commissioner of Sate Tax, Raipur Division 1: Chhattisgarh	30/05
Pfizer : Audited Results – Year ended March 31, 2024	18/05
Pfizer Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	17/05
Pfizer Limited Recommends Dividend for the Financial Year Ended March 31, 2024, Payable on or Before September 6, 2024	17/05
Pfizer Limited has Received an Order Issued by the Assistant Commissioner, GST & Central Excise, Bhubaneswar-II Division Bhubaneswar	02/05
Pfizer Limited Receives Order from Deputy Commissioner, Dehradun - Sector 8: Uttarakhand	25/04
Pfizer Limited Appoints Amit Agarwal as Chief Financial Officer	02/04
Pfizer Limited Appoints Amit Agarwal as Whole-Time Director, Designated as Executive Director Finance	02/04
China's National Medical Products Administration Accepts Astellas and Pfizer's Supplemental Biologics License Application for Enfortumab Vedotin with Keytruda (Pembrolizumab) for First-Line Treatment of Advanced Bladder Cancer	28/03
Pfizer Limited Receives an Order from Joint Commissioner of State Tax Basis the GST Audit Conducted for Uttar Pradesh State for the Financial Year 2018-19	22/03
Pfizer Limited Receives an Order from Deputy Commissioner of State Tax Basis the GST Audit Conducted for the Financial Year 2018-19	19/03
Pfizer Limited Informs Satyen Amin, Lead - Market Access Tenders His Resignation from Employment, with Effect from March 31, 2024	09/02
Pfizer Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	09/02
Pfizer Ltd. Names CFO	22/01
Pfizer CFO Retires	01/12
Pfizer Limited Announces Retirement of Mr. Milind Patil as Chief Financial Officer	30/11
Pfizer Limited Appoints Ms. Aditi Mehta as Category Lead, Vaccines Effective December 1, 2023	16/11
Pfizer Limited Announces Resignation of Mr. Milind Patil as Director with Effect from Close of Business on November 13, 2023	13/11
Pfizer Sees Sharp Fall in Fiscal Q2 Net Profit	30-10-23
Pfizer Limited Announces Resignation of Samir Kazi as Director from the Board of Directors	28-10-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Pfizer Limited Bombay S.E.

Aandelen

PFIZER

INE182A01018

Andere talen

Filters